Who What Wear on MSN

The internet says this viral tool is like a magic wand for puffy eyes—I was skeptical, so I tried it

TikTok fell in love with Therabody's TheraFace Depuffing Wand, so I decided to put it to the test. Read on to see how it transformed my puffy under-eyes.

They Made A $300 Rumble Pack For Your Taint

After years of development, testing, and jumping through various FDA hoops, the Mor “taint bandage” device is now available to buy. Slap this rumble pack on your down-south valley, and you’ll be able ...
PCMag

Is That Video Real? 7 Telltale Signs It's an AI Deepfake

The internet is absolutely overflowing with AI-generated videos, making it difficult to tell what's real. We can help you pick out the deepfakes.
Fierce Pharma

J&J’s Tremfya outstrips AbbVie’s Skyrizi again, closing out 2025 as December’s top TV ad spender

Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
The Escapist

Terra Invicta – here’s a list of console commands to help you bend the space opera to your will

Here’s every working Terra Invicta console command, what they do, and how to enable the debug console in the full release.

How to Get Shrooms

The Shrooms Update landed in Schedule 1 on December 26, 2025, as part of the v0.4.2 patch, introducing mushrooms as a new ...
WebMD

How the New GLP-1 Weight Loss Pill Compares to the Shot

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Medical Dialogues

JnJ Tremfya gets European Commission approval for children with plaque psoriasis

Belgium: Johnson & Johnson has announced that the European Commission has extended the marketing authorisation for TREMFYA (guselkumab) as a subcutaneous treatment to treat moderate to ...
Healio

Leqembi autoinjector easy to use, convenient in early-stage Alzheimer’s

Please provide your email address to receive an email when new articles are posted on . Feasibility and acceptability scores for the autoinjector were highest among health care professionals. All ...
News Medical

Monthly biologic injection improves severe asthma control and reduces steroid use

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...
Berkshire Eagle

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

Additionally, for patients in the study's placebo group, who switched to TREMFYA ® at Week 24, the rate of radiographic progression from baseline to Week 24 (0.96) was reduced by 57% (to 0.41) from ...
Morningstar

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years

*The as observed analysis set included participants who entered the LTE, received ≥1 partial or complete study drug dose during the LTE, remained on treatment, and had data available at Week 96; ...